Description
CJC-1295 / Ipamorelin Blend 10 mg is a dual-action lyophilized formulation containing the GHRH analogue CJC-1295 (No DAC) and the selective GHRP Ipamorelin. In research literature, this specific combination is cited for its potent synergistic effect on the somatotropic axis. While Ipamorelin acts as a selective pulse generator (initiating the GH release), CJC-1295 acts as a somatotrope amplifier (increasing the quantity of GH released per pulse). Researchers utilize this blend to study maximal physiological Growth Hormone secretion without the elevation of stress hormones (cortisol/prolactin) often seen with non-selective agents.
-
Format: Lyophilized Powder (Blend)
-
Purity: ≥99% (HPLC Verified)
-
Research Focus: Synergistic GH Release, Pulse Amplification & Pituitary Signaling
